Findings reveal new target for protecting diabetes patients’ bones

New York University researchers have opened a door to protecting the bones of diabetes patients. They found that hyperglycemic mice had high levels of succinate in their bone marrow, a substance barely detectable in normal mice. Based on their findings, researchers believe that regulating succinate will reduce the high fracture rate and delayed healing process in patients with diabetes.

The researchers collaborated with scientists from Stanford University and Dalian Medical University using NYSERNet’s R&E network.

Read more at: